17-79834299-G-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_003655.3(CBX4):​c.1343C>T​(p.Pro448Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000113 in 1,594,364 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

CBX4
NM_003655.3 missense

Scores

1
7
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.93

Publications

0 publications found
Variant links:
Genes affected
CBX4 (HGNC:1554): (chromobox 4) Enables SUMO binding activity; SUMO ligase activity; and enzyme binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in nuclear body. Part of PRC1 complex. Implicated in hepatocellular carcinoma. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17969468).
BS2
High AC in GnomAd4 at 10 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CBX4NM_003655.3 linkc.1343C>T p.Pro448Leu missense_variant Exon 5 of 5 ENST00000269397.9 NP_003646.2 O00257-1A0A0S2Z5B2
CBX4XM_011525399.3 linkc.1145C>T p.Pro382Leu missense_variant Exon 3 of 3 XP_011523701.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CBX4ENST00000269397.9 linkc.1343C>T p.Pro448Leu missense_variant Exon 5 of 5 1 NM_003655.3 ENSP00000269397.4 O00257-1

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152144
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000294
AC:
6
AN:
203762
AF XY:
0.0000265
show subpopulations
Gnomad AFR exome
AF:
0.000271
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000348
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000555
AC:
8
AN:
1442220
Hom.:
0
Cov.:
32
AF XY:
0.00000279
AC XY:
2
AN XY:
716082
show subpopulations
African (AFR)
AF:
0.000121
AC:
4
AN:
32934
American (AMR)
AF:
0.00
AC:
0
AN:
42548
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25594
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38822
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84474
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49478
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5134
European-Non Finnish (NFE)
AF:
0.00000362
AC:
4
AN:
1103762
Other (OTH)
AF:
0.00
AC:
0
AN:
59474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152144
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41432
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68002
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000869
Hom.:
0
Bravo
AF:
0.0000793
ExAC
AF:
0.0000433
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 12, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1343C>T (p.P448L) alteration is located in exon 5 (coding exon 5) of the CBX4 gene. This alteration results from a C to T substitution at nucleotide position 1343, causing the proline (P) at amino acid position 448 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Uncertain
0.014
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.079
T
Eigen
Benign
0.17
Eigen_PC
Benign
0.10
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.68
T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.18
T
MetaSVM
Benign
-0.77
T
MutationAssessor
Benign
1.8
L
PhyloP100
2.9
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-3.8
D
REVEL
Benign
0.19
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0060
D
Polyphen
0.99
D
Vest4
0.27
MutPred
0.24
Gain of helix (P = 0.0022);
MVP
0.51
MPC
1.9
ClinPred
0.64
D
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.16
gMVP
0.48
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs751578106; hg19: chr17-77808098; API